With recent research, cancer immunotherapy has notably been proven to be effective in eradicating or minimizing the spread of invading primary as well as metastatic tumors. In principle, cancer immunotherapeutics are based on the stimulation of the body’s immune cells against the elimination of cancerous cells; and are accomplished with the help of several methods including but not limited to cytokines, vaccines, adoptive cellular therapy, as well as oncolytic viruses.
Apart from cancers, autoimmune systems have also gained special interest due to the ability of normal immune cells of the body to attack its cells. Accordingly, multiple projects are going on across the world to facilitate different studies including toxicity analysis, graft rejection studies, studies related to inflammation and allergies, drug development, etc.
Kosheeka has a range of primary immune cells including NK cells, dendritic cells, etc.; you just have to design and test treatments as part of your research and development.
- Cytotoxic T cells
- T Helper 1 Cells
- T Helper 2 Cells
- Regulatory T Cells
- B Cells
- Macrophage Cells
- Dendritic Cells
- Natural Killer Cells (NK Cells)
- Muse Cells
- Customized primary cancer cells
- Optimized cell culture growth media